206 related articles for article (PubMed ID: 30047087)
1. Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine.
Jwa MY; Jeong S; Ko EB; Kim AR; Kim HY; Kim SK; Seo HS; Yun CH; Han SH
J Microbiol; 2018 Aug; 56(8):579-585. PubMed ID: 30047087
[TBL] [Abstract][Full Text] [Related]
2. Gamma-irradiation-killed Streptococcus pneumoniae potently induces the expression of IL-6 and IL-8 in human bronchial epithelial cells.
Jwa MY; Ko EB; Kim HY; Kim SK; Jeong S; Seo HS; Yun CH; Han SH
Microb Pathog; 2018 Nov; 124():38-46. PubMed ID: 30114464
[TBL] [Abstract][Full Text] [Related]
3. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
5. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
6. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
[TBL] [Abstract][Full Text] [Related]
7. Th17 activation by dendritic cells stimulated with gamma-irradiated Streptococcus pneumoniae.
Kim HY; Kim SK; Seo HS; Jeong S; Ahn KB; Yun CH; Han SH
Mol Immunol; 2018 Sep; 101():344-352. PubMed ID: 30036800
[TBL] [Abstract][Full Text] [Related]
8. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With
Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS
Front Immunol; 2019; 10():1212. PubMed ID: 31191555
[No Abstract] [Full Text] [Related]
9. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
David SC; Laan Z; Minhas V; Chen AY; Davies J; Hirst TR; McColl SR; Alsharifi M; Paton JC
Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
11. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
12. Recent approaches in vaccine development against Streptococcus pneumoniae.
Tarahomjoo S
J Mol Microbiol Biotechnol; 2014; 24(4):215-27. PubMed ID: 25196525
[TBL] [Abstract][Full Text] [Related]
13. Immune Responses to Irradiated Pneumococcal Whole Cell Vaccine.
Ko E; Jeong S; Jwa MY; Kim AR; Ha YE; Kim SK; Jeong S; Ahn KB; Seo HS; Yun CH; Han SH
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33921842
[No Abstract] [Full Text] [Related]
14. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
[TBL] [Abstract][Full Text] [Related]
16. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
[TBL] [Abstract][Full Text] [Related]
17. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
Huang J; Luo S; Huang M; Zhang T; Min Z; Liu C; Zhang Q; Yang J; Min X
Microb Pathog; 2019 Apr; 129():206-212. PubMed ID: 30772476
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice.
Roche AM; King SJ; Weiser JN
Infect Immun; 2007 May; 75(5):2469-75. PubMed ID: 17339359
[TBL] [Abstract][Full Text] [Related]
20. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
